MH Rosove, P Brewer - Annals of internal medicine, 1992 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To determine the clinical
course and influence of antithrombotic therapy in patients with lupus anticoagulant or ... Cited by 478 - Related articles - All 4 versions
- ►fesemi.org [PDF] MA Khamashta, MJ Cuadrado, F Mujic, NA … - The New England …, 1995 - nejm.highwire.org Vol. 332 No. 15 MANAGEMENT OF THROMBOSIS IN THE ANTIPHOSPHOLIPID-ANTIBODY
SYNDROME ... THE MANAGEMENT OF THROMBOSIS IN THE ANTIPHOSPHOLIPID-ANTIBODY
SYNDROME ... M UNTHER A. K HAMASHTA , MD, M ARIA J OSE C UADRADO , MD, F ... Cited by 1088 - Related articles - BL Direct - All 12 versions
- ►bmj.com [PDF] RH Derksen, PG De Groot, L Kater, HK … - British Medical Journal, 1993 - ard.bmj.com Abstract Objective-To determine whether the finding of antiphospholipid antibodies in patients
with venous thromboembolic episodes should influence the duration of treatment with anticoagulant
drugs by mouth. Methods-A retrospective study was carried out in 19 patients with ... Cited by 167 - Related articles - BL Direct - All 7 versions
G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG … - The American journal of …, 1996 - Elsevier Thirty-four patients developed a thrombotic complication, with a total incidence of 2.5%
patient-years. Multivariate logistic regression analysis identified two independent risk factors
for thrombotic events: a previous thrombosis (RR 4.9; 95% Cl, 1.76 to 13.7; P < 0.005) ... Cited by 301 - Related articles - BL Direct - All 7 versions
MA Crowther, JS Ginsberg, J Julian, J … - The New England …, 2003 - nejm.highwire.org Methods We performed a randomized, double-blind trial in which patients with antiphospholipid
antibodies and previous thrombosis were assigned to receive enough warfarin to achieve an
INR of 2.0 to 3.0 (moderate intensity) or 3.1 to 4.0 (high intensity). Our objective was to ... Cited by 353 - Related articles - BL Direct - All 6 versions
KS Ginsburg, MH Liang, L Newcomer, SZ … - Annals of internal …, 1992 - Am Coll Physicians Participants: The study sample was drawn from the Physicians' Health Study, a randomized,
double-blind, placebo-controlled trial of aspirin and beta-carotene in 22 071 male
physicians. At entry, 68% of the participants submitted plasma samples that were ... Cited by 380 - Related articles - All 5 versions
- ►hematologylibrary.org [PDF] JS Ginsberg, PS Wells, P Brill-Edwards, D … - …, 1995 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ... Cited by 286 - Related articles - BL Direct - All 7 versions
S Krnic-Barrie, CR O'Connor, SW Looney, … - Archives of Internal …, 1997 - archinte.highwire.org Page 1. A Retrospective Review of 61 Patients With Antiphospholipid Syndrome Analysis of
Factors Influencing Recurrent Thrombosis Sanja Krnic-Barrie, MD; Carolyn Riester O'Connor,
MD; Stephen W. Looney, PhD; Silvia S. Pierangeli, PhD; E. Nigel Harris, MPhil, MD, DM ... Cited by 137 - Related articles - BL Direct - All 5 versions
MD Schulman… - The American journal of medicine, 1998 - Elsevier Results: Among the 412 patients with a first episode of venous thromboembolism the risk of recurrence
was 29% in patients with anticardiolipin antibodies and 14% in those without antibodies (P =
0.0013). In those with antibodies, there was an increased risk during the first 6 months ... Cited by 232 - Related articles - BL Direct - All 3 versions
JL Vianna, MA Khamashta, J Ordi-Ros, J Font, … - The American journal of …, 1994 - ncbi.nlm.nih.gov PURPOSE: To determine whether the features of the antiphospholipid syndrome (APS) are in
any way influenced by the presence or absence of systemic lupus erythematosus (SLE). We
followed up patients with 'primary' APS (PAPS) and APS secondary to SLE (APS plus ... Cited by 288 - Related articles - BL Direct - All 2 versions
